The PFO Consortium is approaching the target sample size of 1500 patients!
We would like to thank all centers for their outstanding ongoing effort! A manuscript of a preliminary analysis of the baseline data of 1000 patients is in preparation. So far, we would like to share with you a few details about the collected data:
Patients with closure: 582
New patients since last month: 6
Average age: 59
Ratio male / female: 945 / 558
Oral presentation at the International Stroke Conference in Nashville
In February 2015, results of an interim analysis of our study were presented during the International Stroke Conference 2015 in Nashville (TN). We compared 114 patients with both clinical and radiological evidence of previous stroke with 661 patients with first-‐ever clinical and radiological stroke. We found that vascular risk factors, age and the antiphospholipid-‐antibody-‐syndrom but not TEE features were associated with stroke recurrence in patients with cryptogenic stroke and PFO. The full presentation is attached.
Save the date! 3rd European PFO Summit in Zurich on October 16, 2015
After the great success of the 2nd European PFO Summit, a third one will take place on October 16, 2015 in Zürich, Switzerland. An exciting meeting is being planned. The topics of the main sessions will be: embolic stroke, embolic stroke of unknown source and PFO-‐related stroke. There will also be two workshops: “Percutaneous closure of PFO” and “Detection of Right-‐to-‐Left-‐Shunt”. The program is attached. You are warmly invited to attend the summit!
New study coordinator
After four years of unparalleled commitment to the PFO consortium, Barbara Mangold is leaving us. Her job will be taken over by Sylvie Nuc. Mrs. Nuc will start her new job in July 2015. Until then, you may contact Marie-Luise Mono, Executive Director of the PFO Consortium (marie-luise.mono<at>insel.ch) for all questions that might come up with regard to the study. We would like to thank Mrs. Mangold for the excellent work and welcome Mrs. Nuc to her new position.